Aura Biosciences Inc (AURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,466 | -58,763 | -42,204 | -26,303 | -12,835 |
| Depreciation Amortization | 328 | 1,177 | 854 | 552 | 256 |
| Accounts payable and accrued liabilities | -1,881 | 340 | -678 | -1,515 | -757 |
| Other Working Capital | -514 | -3,846 | 174 | -2,811 | -4,251 |
| Other Operating Activity | 3,121 | 6,491 | 5,266 | 4,249 | 2,387 |
| Operating Cash Flow | $-16,412 | $-54,601 | $-36,588 | $-25,828 | $-15,200 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -66,770 | -66,775 | -50,257 | -68,266 | -24,899 |
| PPE Investments | -109 | -1,094 | -736 | -673 | -599 |
| Investing Cash Flow | $-66,879 | $-67,869 | $-50,993 | $-68,939 | $-25,498 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 201 | 95,629 | 430 | 326 | 17 |
| Financing Cash Flow | $201 | $95,629 | $430 | $326 | $17 |
| Beginning Cash Position | 122,370 | 149,211 | 149,211 | 149,211 | 149,211 |
| End Cash Position | 39,280 | 122,370 | 62,060 | 54,770 | 108,530 |
| Net Cash Flow | $-83,090 | $-26,841 | $-87,151 | $-94,441 | $-40,681 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,412 | -54,601 | -36,588 | -25,828 | -15,200 |
| Capital Expenditure | -109 | -1,094 | -736 | -673 | -599 |
| Free Cash Flow | -16,521 | -55,695 | -37,324 | -26,501 | -15,799 |